Shan, H.; Zhang, X.; Mi, Y.; Jia, J.; Wang, B.; Yang, Q.
Eriodictyol Suppresses Gastric Cancer Cells via Inhibition of PI3K/AKT Pathway. Pharmaceuticals 2022, 15, 1477.
https://doi.org/10.3390/ph15121477
AMA Style
Shan H, Zhang X, Mi Y, Jia J, Wang B, Yang Q.
Eriodictyol Suppresses Gastric Cancer Cells via Inhibition of PI3K/AKT Pathway. Pharmaceuticals. 2022; 15(12):1477.
https://doi.org/10.3390/ph15121477
Chicago/Turabian Style
Shan, Hui, Xin Zhang, Yalu Mi, Jihui Jia, Bo Wang, and Qing Yang.
2022. "Eriodictyol Suppresses Gastric Cancer Cells via Inhibition of PI3K/AKT Pathway" Pharmaceuticals 15, no. 12: 1477.
https://doi.org/10.3390/ph15121477
APA Style
Shan, H., Zhang, X., Mi, Y., Jia, J., Wang, B., & Yang, Q.
(2022). Eriodictyol Suppresses Gastric Cancer Cells via Inhibition of PI3K/AKT Pathway. Pharmaceuticals, 15(12), 1477.
https://doi.org/10.3390/ph15121477